Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.515 USD | +1.69% | -6.04% | +72.80% |
May. 07 | Citigroup Starts Summit Therapeutics With Buy Rating, $7 Price Target | MT |
May. 01 | Transcript : Summit Therapeutics Inc., Q1 2024 Earnings Call, May 01, 2024 |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.45B 3.12B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 105 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.86% |
Latest transcript on Summit Therapeutics Inc.
1 day | -1.55% | ||
1 week | -4.52% | ||
Current month | +12.98% | ||
1 month | +26.86% | ||
3 months | -12.43% | ||
6 months | +130.05% | ||
Current year | +70.11% |
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 4.515 | +1.69% | 611 390 |
24-05-17 | 4.44 | -1.55% | 1,180,801 |
24-05-16 | 4.51 | +0.45% | 1,323,617 |
24-05-15 | 4.49 | -4.16% | 1,836,454 |
24-05-14 | 4.685 | -2.40% | 1,667,094 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+70.11% | 3.12B | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.30% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- SMMT Stock